Skip to main navigation Skip to search Skip to main content

International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE

  • the Consise Laboratory Working Group Participants
  • Peter Doherty Institute for Infection and Immunity
  • National Institute for Biological Standards and Control
  • TB Laboratory Research, CDC
  • The University of Hong Kong Li Ka Shing Faculty of Medicine
  • Imperial College London
  • Norwegian Institute of Public Health
  • World Health Organization
  • Institut Pasteur, Paris
  • Siriraj Hospital
  • Italian National Institute of Health
  • NIH
  • National Institute of Virology India
  • U.S. Naval Health Research Center
  • Naval Medical Research Center
  • Paul-Ehrlich Institute
  • Università di Siena
  • Chinese National Influenza Center
  • Victorian Infectious Diseases Reference Laboratory

Research output: Contribution to journalArticlepeer-review

41 Citations (Scopus)

Abstract

The microneutralization assay is commonly used to detect antibodies to influenza virus, and multiple protocols are used worldwide. These protocols differ in the incubation time of the assay as well as in the order of specific steps, and even within protocols there are often further adjustments in individual laboratories. The impact these protocol variations have on influenza serology data is unclear. Thus, a laboratory comparison of the 2-day enzyme-linked immunosorbent assay (ELISA) and 3-day hemagglutination (HA) microneutralization (MN) protocols, using A(H1N1)pdm09, A(H3N2), and A(H5N1) viruses, was performed by the CONSISE Laboratory Working Group. Individual laboratories performed both assay protocols, on multiple occasions, using different serum panels. Thirteen laboratories from around the world participated. Within each laboratory, serum sample titers for the different assay protocols were compared between assays to determine the sensitivity of each assay and were compared between replicates to assess the reproducibility of each protocol for each laboratory. There was good correlation of the results obtained using the two assay protocols in most laboratories, indicating that these assays may be interchangeable for detecting antibodies to the influenza A viruses included in this study. Importantly, participating laboratories have aligned their methodologies to the CONSISE consensus 2-day ELISA and 3-day HAMNassay protocols to enable better correlation of these assays in the future.

Original languageEnglish
Pages (from-to)957-964
Number of pages8
JournalClinical and Vaccine Immunology
Volume22
Issue number8
DOIs
Publication statusPublished - 1 Aug 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE'. Together they form a unique fingerprint.

Cite this